Choo Chee Kong - 14 Jul 2026 Form 4/A - Amendment Insider Report for CytoMed Therapeutics Ltd (GDTC)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GDTC
Reported as of: 14 Jul 2026
Net transaction value: +$300,000
SEC form: 4/A - Amendment
Accepted by SEC: 24 Jul 2026, 21:01:08 UTC
Original report date: 24 Jul 2026
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ CHOO CHEE KONG

Key filing fact

Choo Chee Kong filed Form 4/A - Amendment for CytoMed Therapeutics Ltd (GDTC) on 24 Jul 2026.

Key facts

This page summarizes Choo Chee Kong's Form 4/A - Amendment filing for CytoMed Therapeutics Ltd (GDTC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Jul 2026, 21:01.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: +$300,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001970632 Primary reporting owner

Choo Chee Kong

Relationship: Director, 10%+ Owner
Address: #08-22 ONE COMMONWEALTH, 1, COMMONWEALTH LANE, SINGAPORE, SINGAPORE
Signature: /s/ CHOO CHEE KONG
Signature date: 24 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDTC transaction

ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED

Purchase

Transaction value: $150,000
Shares: +100,000
Change %: +23%
Price: $1.50
Shares after: 530,324
Date: 14 Jul 2026
Ownership: Direct
Footnotes: F1

GDTC transaction

ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED

Purchase

Transaction value: $150,000
Shares: +100,000
Change %: +19%
Price: $1.50
Shares after: 630,324
Date: 20 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made.